Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
318 hedge funds and large institutions have $1.9B invested in Avanos Medical in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 103 reducing their positions, and 36 closing their positions.
25% more call options, than puts
Call options by funds: $2.24M | Put options by funds: $1.79M
12% more capital invested
Capital invested by funds: $1.69B → $1.9B (+$208M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 328 → 318 (-10)
17% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 36
20% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 103
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$18.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$16.6M |
| 3 |
TA
Teachers Advisors
New York
|
+$11.8M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$9.97M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$34.1M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$19.2M |
| 3 |
Goldman Sachs
New York
|
-$10.5M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$7.72M |
| 5 |
AP
AHL Partners
London,
United Kingdom
|
-$7.01M |
AVNS Hedge Fund Activity: Q3 2017 in Review
318 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2017, worth a combined $1.9B — up 12% from $1.69B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of AVNS and 30 opened new positions — a net loss of 6 holders — while 103 trimmed existing stakes and 82 added.
The largest buyer was Macquarie Group, opening a new position worth an estimated $18.1M. The largest seller was Citadel Advisors, exiting entirely with an estimated $34.1M sold.
- 318 institutional investors held Avanos Medical (AVNS) as of Q3 2017, down from 328 in Q2 2017.
- Funds reported $1.9B of Avanos Medical stock for Q3 2017, up 12% quarter-over-quarter.
- 30 funds opened new Avanos Medical positions in Q3 2017 and 36 closed out, a net change of -6 holders.
- The largest Avanos Medical buyer in Q3 2017 was Macquarie Group, an estimated $18.1M added.
- The largest Avanos Medical seller in Q3 2017 was Citadel Advisors, an estimated $34.1M sold.
Based on aggregated 13F filings for Q3 2017.